Teriflunomide may temper lesion growth in children with multiple sclerosis: Lancet Hina Zahid7 Dec 2021 9:00 AM ISTThere are few treatment options for children with multiple sclerosis -- a condition in which the immune system attacks the protective covering of...
Study Finds Vitamin D Involvement in Cognition of Multiple Sclerosis MD Bureau4 Dec 2021 11:00 AM ISTIn past decades, cognitive impairment (CI) was underestimated in multiple sclerosis (MS) patients and thought to appear only in primary progressive...
9-Hole Peg Test useful for detecting motor impairments in multiple sclerosis patients: Study Medha Baranwal4 Dec 2021 9:00 AM ISTUSA: The 9-Hole Peg Test could be a useful tool for assessing motor impairments in patients with multiple sclerosis (MS), suggests a recent study....
Setback: Biogen loses bid to revive patent on Mylan blockbuster MS drug Tecfidera Ruchika Sharma3 Dec 2021 5:07 PM ISTTecfidera, on the market since 2013, has been key to Biogen's fortunes while it struggles to find new medicines to make up for declining revenue.
ANI Pharma Cortrophin Gel gets USFDA nod for certain chronic autoimmune disorders Ruchika Sharma4 Nov 2021 9:30 AM ISTBaudette: ANI Pharmaceuticals, Inc. has recently announced that the U.S. Food and Drug Administration (FDA) has approved the Company's...
Having MS plus depression may be tied to increased risk of death, finds study Hina Zahid7 Sept 2021 7:45 AM ISTMINNEAPOLIS - Depression is common in people with multiple sclerosis (MS), and a new study shows that people with both conditions may be more likely...
Zydus Cadila gets USFDA nod for multiple sclerosis drug Fingolimod Medical Dialogues Bureau25 Jun 2021 1:00 PM ISTFingolimod is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis.
New MRI technique can facilitate disability prediction in multiple sclerosis patients: Study Medha Baranwal1 May 2021 10:30 AM ISTUK: Advanced MRI techniques can aid in detecting very early changes in the brain of patients with multiple sclerosis (MS) this may lead to more...
Ponesimod bests teriflunomide in lowering relapse rates of multiple sclerosis; JAMA Dr Satabdi Saha10 April 2021 4:15 AM ISTPonesimod was superior to for relapsing multiple sclerosis, in terms of reducing relapse rates, unique active lesions on MRI, and fatigue symptoms,...
FDA allows marketing of Device to Improve Gait in Multiple Sclerosis Patients Hina Zahid30 March 2021 8:56 AM ISTThe U.S. Food and Drug Administration has authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild...
Siponimod May Improve Thinking Skills in Advanced Multiple Sclerosis: Study Hina Zahid17 Dec 2020 2:45 PM ISTMINNEAPOLIS - Researchers have found in a new study that people with the advanced form of multiple sclerosis (MS) called secondary progressive MS who...
Multiple sclerosis may not increase risk for breast, colorectal cancers: Study Hina Zahid27 Nov 2020 4:30 PM ISTMINNEAPOLIS - People with multiple sclerosis (MS) may not be at higher risk of developing two of the three cancers that occur most commonly in people...
